| Index | — | P/E | 32.94 | EPS (ttm) | 5.30 | Insider Own | 2.11% | Shs Outstand | 31.88M | Perf Week | 2.33% |
| Market Cap | 5.57B | Forward P/E | 30.54 | EPS next Y | 5.72 | Insider Trans | — | Shs Float | 31.60M | Perf Month | 4.83% |
| Enterprise Value | 5.64B | PEG | — | EPS next Q | 1.38 | Short Float | 1.64% | Perf Quarter | -0.10% | ||
| Income | 171.00M | P/S | 5.01 | EPS this Y | 16.27% | Short Ratio | 2.50 | Perf Half Y | 7.71% | ||
| Sales | 1.11B | P/B | 4.19 | EPS next Y | 4.32% | ROA | 10.03% | Short Interest | 517.05K | Perf YTD | 13.85% |
| Book/sh | 41.63 | P/C | 84.33 | EPS next 5Y | — | ROE | 13.21% | 52W High | 183.90 -5.06% | Perf Year | 13.40% |
| Cash/sh | 2.07 | P/FCF | 26.76 | EPS past 3/5Y | 13.48% 12.81% | ROIC | 11.92% | 52W Low | 147.18 18.63% | Perf 3Y | 43.49% |
| Dividend Est. | 0.40 (0.23%) | EV/EBITDA | 20.59 | Sales past 3/5Y | 3.25% 8.05% | Gross Margin | 36.46% | Volatility | 2.20% 2.10% | Perf 5Y | 12.98% |
| Dividend TTM | 0.96 (0.55%) | EV/Sales | 5.08 | EPS Y/Y TTM | 15.97% | Oper. Margin | 21.40% | ATR (14) | 3.73 | Perf 10Y | 129.89% |
| Dividend Ex-Date | Dec 31, 2026 | Quick Ratio | 1.39 | Sales Y/Y TTM | 9.47% | Profit Margin | 15.41% | RSI (14) | 58.49 | Recom | 2.40 |
| Dividend Gr. 3/5Y | 10.58% 10.60% | Current Ratio | 2.47 | EPS Q/Q | 16.30% | SMA20 | 2.66% | Beta | 0.85 | Target Price | 212.50 |
| Payout | 18.02% | Debt/Eq | 0.11 | Sales Q/Q | 8.58% | SMA50 | 2.68% | Rel Volume | 0.72 | Prev Close | 169.98 |
| Employees | 1,379 | LT Debt/Eq | 0.10 | Earnings | Feb 19 | SMA200 | 3.13% | Avg Volume | 228.34K | Price | 174.60 |
| IPO Date | Jun 03, 1986 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 9.79% 0.49% | Net Debt/EBITDA | 0.28 | Volume | 163,758 | Change | 2.72% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-23-26 | Reiterated | HC Wainwright & Co. | Buy | $215 → $210 |
| Aug-03-26 | Reiterated | UBS | $190 → $215 | |
| Aug-03-26 | Reiterated | HC Wainwright & Co. | Buy | $189 → $215 |
| Dec-05-25 | Initiated | Rothschild & Co Redburn | Neutral | $162 |
| Aug-04-25 | Reiterated | HC Wainwright & Co. | Buy | $180 → $189 |
| Apr-28-25 | Reiterated | HC Wainwright & Co. | Buy | $190 → $180 |
| Nov-04-24 | Reiterated | HC Wainwright & Co. | Buy | $152 → $190 |
| May-02-22 | Reiterated | HC Wainwright & Co. | Buy | $152 |
| Feb-22-22 | Upgrade | Sidoti & Co. | Neutral → Buy | |
| Nov-29-21 | Downgrade | Sidoti & Co. | Buy → Neutral |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,110 | 1,037 | 954 | 922 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 705 | 667 | 617 | 620 | — | — | — | — | — | |
| Gross Profit | 405 | 371 | 336 | 302 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 122 | 143 | 137 | 130 | — | — | — | — | — | |
| Research and Development | 21 | 19 | 17 | 15 | — | — | — | — | — | |
| Other Operating Expense | 23 | -10 | -1 | -2 | — | — | — | — | — | |
| Operating Income | 237 | 218 | 183 | 159 | — | — | — | — | — | |
| Interest Expense | 8 | 10 | 17 | 23 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -8 | -9 | 0 | 1 | — | — | — | — | — | |
| Net Income Before Taxes | 221 | 199 | 166 | 137 | — | — | — | — | — | |
| Income Taxes | 49 | 44 | 38 | 29 | — | — | — | — | — | |
| Consolidated Net Income | 171 | 155 | 128 | 109 | — | — | — | — | — | |
| Net Income From Continuing Operations | 171 | 155 | 128 | 109 | — | — | — | — | — | |
| Net Income | 171 | 155 | 128 | 109 | — | — | — | — | — | |
| EPS (Recurring) | 5.34 | 4.80 | 3.97 | 3.38 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 5.34 | 4.80 | 3.97 | 3.38 | — | — | — | — | — | |
| EPS (Diluted) | 5.30 | 4.75 | 3.93 | 3.35 | — | — | — | — | — | |
| EBITDA | 274 | 255 | 231 | 215 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 32.94 | 32.29 | 41.48 | 44.40 | — | — | — | — | — | |
| Price To Sales Ratio | 5.03 | 4.88 | 5.47 | 5.16 | — | — | — | — | — | |
| Gross Margin | 36.49 | 35.78 | 35.22 | 32.75 | — | — | — | — | — | |
| Operating Margin | 21.35 | 21.02 | 19.18 | 17.25 | — | — | — | — | — | |
| Net Margin | 15.41 | 14.95 | 13.42 | 11.82 | — | — | — | — | — | |
| Shares Outstanding | 32 | 33 | 32 | 32 | — | — | — | — | — | |
| Market Capitalization | 5,587 | 5,061 | 5,216 | 4,760 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| van Gunsteren Job Leonard | SVP and GM, Specialty Products | Dec 04 '25 | Sale | 153.29 | 6,000 | 919,723 | 9,446 | Dec 05 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products | Dec 04 '25 | Option Exercise | 60.85 | 12,000 | 730,200 | 15,446 | Dec 05 |
| Fischer David B | Director | Dec 03 '25 | Sale | 153.97 | 8,000 | 1,231,749 | 7,989 | Dec 05 |
| Fischer David B | Director | Dec 03 '25 | Option Exercise | 78.72 | 6,000 | 472,334 | 15,989 | Dec 05 |
| Reid Martin Luther | SVP Chief Supply Chain Officer | Nov 11 '25 | Sale | 154.44 | 1,200 | 185,328 | 7,391 | Nov 13 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products | Jul 31 '24 | Option Exercise | 59.65 | 7,750 | 462,268 | 16,290 | Aug 02 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products | Jul 31 '24 | Sale | 180.05 | 7,750 | 1,395,412 | 8,540 | Aug 02 |
| Backus William A. | VP & Chief Accounting Officer | Jul 30 '24 | Option Exercise | 84.09 | 3,900 | 327,951 | 8,888 | Aug 01 |
| Backus William A. | VP & Chief Accounting Officer | Jul 30 '24 | Sale | 178.93 | 4,804 | 859,560 | 132 | Aug 01 |
| Sestrick Michael Robert | SVP & Chief Technology Officer | May 10 '24 | Sale | 154.45 | 1,929 | 297,935 | 4,878 | May 13 |
| Fischer David B | Director | May 08 '24 | Sale | 152.98 | 5,000 | 764,901 | 9,009 | May 10 |
| Tignor Michael Brent | SVP & Chief HR Officer | Mar 08 '24 | Option Exercise | 85.40 | 4,200 | 358,680 | 13,707 | Mar 12 |
| Tignor Michael Brent | SVP & Chief HR Officer | Mar 08 '24 | Sale | 157.52 | 5,339 | 840,985 | 8,368 | Mar 12 |
| Wineinger Matthew David | Director | Mar 04 '24 | Sale | 156.89 | 1,333 | 209,128 | 6,162 | Mar 06 |
| Backus William A. | VP & Chief Accounting Officer | Feb 26 '24 | Sale | 155.19 | 7,000 | 1,086,305 | 5,914 | Feb 27 |